Pages that link to "Q36210285"
Jump to navigation
Jump to search
The following pages link to Update on fibroblast growth factor 23 in chronic kidney disease (Q36210285):
Displaying 50 items.
- FGF23 in Acute and Chronic Illness (Q26778554) (← links)
- Fibroblast growth factor 23 (Q26829294) (← links)
- Cardiorenal syndrome: the emerging role of protein-bound uremic toxins (Q26830674) (← links)
- Fibroblast Growth Factor 23: A New Dimension to Diseases of Calcium-Phosphorus Metabolism (Q26866263) (← links)
- Prevalence and prognostic implications of vitamin D deficiency in chronic kidney disease (Q27022366) (← links)
- FGF23 signaling impairs neutrophil recruitment and host defense during CKD. (Q27330325) (← links)
- Functional diversity of fibroblast growth factors in bone formation (Q28086929) (← links)
- High dietary phosphorus intake is associated with all-cause mortality: results from NHANES III. (Q30564821) (← links)
- FGF23/FGFR4-mediated left ventricular hypertrophy is reversible (Q33694566) (← links)
- Association of Vitamin D Metabolites with Parathyroid Hormone, Fibroblast Growth Factor-23, Calcium, and Phosphorus in Dogs with Various Stages of Chronic Kidney Disease (Q33698568) (← links)
- Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2-4 (Q33715785) (← links)
- FGF23 is synthesised locally by renal tubules and activates injury-primed fibroblasts (Q33793927) (← links)
- Effect of niacin on FGF23 concentration in chronic kidney disease (Q33914268) (← links)
- Association of serum levels of FGF23 and α-Klotho with glomerular filtration rate and proteinuria among cardiac patients (Q34204949) (← links)
- Serum phosphorus and mortality in the Third National Health and Nutrition Examination Survey (NHANES III): effect modification by fasting. (Q34254746) (← links)
- Fibroblast growth factor-23 in obese, normotensive adolescents is associated with adverse cardiac structure (Q34255342) (← links)
- The role of the gastrointestinal tract in phosphate homeostasis in health and chronic kidney disease (Q34337575) (← links)
- Bone: a new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders. (Q34418714) (← links)
- Elevated cardiac markers in chronic kidney disease as a consequence of hyperphosphatemia-induced cardiac myocyte injury (Q34428293) (← links)
- Serum fibroblast growth factor-23 is associated with incident kidney disease (Q34787817) (← links)
- Association between circulating fibroblast growth factor 23, α-Klotho, and the left ventricular ejection fraction and left ventricular mass in cardiology inpatients (Q34988878) (← links)
- Fibroblast growth factor-23 and incident coronary heart disease, heart failure, and cardiovascular mortality: the Atherosclerosis Risk in Communities study (Q35021985) (← links)
- Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease (Q35067500) (← links)
- High dose intravenous iron, mineral homeostasis and intact FGF23 in normal and uremic rats (Q35077013) (← links)
- A longitudinal study of inflammation, CKD-mineral bone disorder, and carotid atherosclerosis after renal transplantation (Q35144464) (← links)
- Competitive interaction between fibroblast growth factor 23 and asymmetric dimethylarginine in patients with CKD. (Q35228536) (← links)
- Soluble Klotho Protects against Uremic Cardiomyopathy Independently of Fibroblast Growth Factor 23 and Phosphate (Q35550609) (← links)
- Treatment of established left ventricular hypertrophy with fibroblast growth factor receptor blockade in an animal model of CKD. (Q35588217) (← links)
- Management of hyperphosphataemia in chronic kidney disease-challenges and solutions (Q35608435) (← links)
- Relation between Red Cell Distribution Width and Fibroblast Growth Factor 23 Cleaving in Patients with Chronic Kidney Disease and Heart Failure (Q35665003) (← links)
- Bone Remodeling and Energy Metabolism: New Perspectives. (Q35755044) (← links)
- Deregulated Renal Calcium and Phosphate Transport during Experimental Kidney Failure (Q35841012) (← links)
- Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study (Q35998095) (← links)
- Effect of oral sodium bicarbonate on fibroblast growth factor-23 in patients with chronic kidney disease: a pilot study (Q36096345) (← links)
- Increased FGF23 serum level is associated with unstable carotid plaque in type 2 diabetic subjects with internal carotid stenosis (Q36156920) (← links)
- Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy (Q36348861) (← links)
- A Prospective Cohort Study of Mineral Metabolism After Kidney Transplantation (Q36381365) (← links)
- Expression of fgf23 and αklotho in developing embryonic tissues and adult kidney of the zebrafish, Danio rerio (Q36460765) (← links)
- αKlotho: FGF23 coreceptor and FGF23-regulating hormone (Q36498135) (← links)
- Renal Function and Bone Loss in a Cohort of Afro-Caribbean Men. (Q36643137) (← links)
- Cord Blood Ferritin and Fibroblast Growth Factor-23 Levels in Neonates (Q36935548) (← links)
- Serum fibroblast growth factor-23 and incident hypertension: the Atherosclerosis Risk in Communities (ARIC) Study (Q37107611) (← links)
- Associations between fibroblast growth factor 23 and cardiac characteristics in pediatric heart failure (Q37126261) (← links)
- Single FGF-23 measurement and time-averaged plasma phosphate levels in hemodialysis patients. (Q37212400) (← links)
- Inflammation regulates fibroblast growth factor 23 production (Q37243107) (← links)
- Proteomic Biomarkers Panel: New Insights in Chronic Kidney Disease. (Q37271191) (← links)
- Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation (Q37280819) (← links)
- Neutrophil Gelatinase-Associated Lipocalin, Fibroblast Growth Factor 23, and Soluble Klotho in Long-Term Kidney Donors (Q37439484) (← links)
- Fibroblast growth factor-23 and cardiovascular events in CKD. (Q37524119) (← links)
- Ferric citrate hydrate for the treatment of hyperphosphatemia in nondialysis-dependent CKD. (Q37621547) (← links)